Overview
Polmedi Group develops medical software for treating chronic and postoperative wounds and for remotely supporting patients before surgery. Its iWound systems include a patient app, tools for consultants and pharmacies, and virtual wound-care consultations. The company also develops the WARMIE wearable for continuous body-temperature monitoring.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-07-11. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
10 public aid cases recorded, with a total value of $838,212.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 13, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,410$1,410 | Marszałek Województwa Wielkopolskiego | |
| Aug 22, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $7,842$7,842 | Fundacja Klaster Lifescience Kraków | |
| Jun 29, 2021 | Aid for research and development projects: experimental development | $407.8K$407,786 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-03-01 | Zwiększenie efektywności terapii podciśnieniowej ran w oparciu o stały monitoring temperatury rany w trakcie trwania terapii NPWT oraz dobór i personalizację trybów pracy urządzenia względem pacjenta i parametrów rany przy wykorzystaniu zaawansowanych algorytmów medycznych | $617.0K$617,038 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
For submitting declarations of will, signing documents on behalf of the company and granting powers of attorney, each member of the management board is authorised independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Banasiewicz (57) | 140 | $1,890.87 | 25.1799% |
Marcin Maciej Cieślak (61) | 78 | $1,053.48 | 14.0288% |
Paweł Edward Cyrson (51) | 78 | $1,053.48 | 14.0288% |
Krzysztof Łuczak | 88 | $1,188.55 | 15.8273% |
Others | 172 | $2,323.07 | 30.9352% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wamedicsp. z o.o. + limited partnership | $151,080.98 | wamedic.pl | ||
| Medway Health Innovation & Servicesp. z o.o. | $101,080.04 | medway.pl | ||
| Medifinesp. z o.o. | $85,375.19 | medifine.pl | ||
| GLAD Futuresp. z o.o. | $83,211.54 | gladfuture.com | ||
| Wellsisp. z o.o. | $77,570.50 | wellsi.app | ||
| 2R Systemssp. z o.o. | $70,179.02 | 2rsystems.pl | ||
| Apps4medsp. z o.o. | $68,254.41 | apps4med.pl | ||
| Algomedicasp. z o.o. | $48,251.24 | algomedica.tech | ||
| MDWsp. z o.o. | $40,538.67 | emdewu.pl | ||
| HealthnomicS.A. | $33,984.62 | healthnomic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-08-01 | Share capital change (13,900.00 PLN → 27,800.00 PLN) | |
| 2025-08-01 | Name change (Warmie → Polmedi Group) | |
| 2025-08-01 | PKD change (Removed: 46.46, 47.74, 72.19.Z; Added: 26.11.Z, 47.74.Z, 47.78.Z, 62.10.B, 72.1, 74.9) | |
| 2024-03-26 | Share capital change (10,000.00 PLN → 13,900.00 PLN) | |
| 2020-03-12 | PKD change (Added: 32.50, 46.46, 47.74) |
FAQ
Last updated: 2026-04-13